Amlodipine and enalapril in coronary disease
Rosa, E.Maffini.da.; Fedrizzi el Andari, C.; Spagnól, M.Fernando.
Arquivos Brasileiros de Cardiologia 94(3): 403; Author Reply 404 427; Author Reply 428
2010
ISSN/ISBN: 0066-782X PMID: 20730272 Document Number: 645962
Document emailed within 1 workday
Related Documents
Saino, A.; Pomidossi, G.; Perondi, R.; Gregorini, L.; Rimini, A.; Alessio, P.; Zanchetti, A.; Mancia, G. 1994: Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease Journal of Cardiovascular Pharmacology 24(6): 875-882Jensen, H.; Garsdal, P.; Davies, J. 1990: Amlodipine with enalapril therapy in moderate-severe essential hypertension Journal of Human Hypertension 4(5): 541-545
Alekseenko, S.A.; Timoshin, S.S.; Avilova, A.A.; Fleĭshman, M.Iu.; Lamekhova, V.G. 2004: Effect of enalapril, lisinopril, and amlodipine on the course of chronic gastrititis in patients with arterial hypertension Klinicheskaia Meditsina 82(9): 42-45
Dong, J.; Chen, X.; So, Y.; Xin, H.; Jiang, W.; Jiang, L. 2009: Intermedin (IMD) gene expression in hypertrophic cardiac myocyte of renal vascular hypertension rats and the intervention of Valsartan, Amlodipine and Enalapril in the expression Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(5): 1082-1087
Kalyuzhin, V.V.; Teplyakov, A.T.; Pushnikova, E.Y.; Bespalova, L.D.; Kalyuzhina, E.V.; Kolesnikov, R.N. 2013: Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome Terapevticheskii Arkhiv 85(5): 68-72
Omvik, P.; Thaulow, E.; Herland, O.B.; Eide, I.; Midha, R.; Turner, R.R. 1994: A long-term, double-blind, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study British Journal of Clinical Practice. Supplement 73: 23-30
Omvik, P.; Thaulow, E.; Herland, O.B.; Eide, I.; Midha, R.; Turner, R.R. 1993: A double-blind, long-term, comparative study on quality of life, safety, and efficacy during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study Journal of Cardiovascular Pharmacology 22 Suppl A: S13-S19
Gan'shina, T.S.; Kim, G.A.; Gnezdilova, A.V.; Gorbunov, A.A.; Mirzoian, R.S. 2014: Comparative study of the effect of S-amlodipine nicotinate and amlodipine benzylate on the arterial pressure of awake rats Eksperimental'naia i Klinicheskaia Farmakologiia 77(8): 20-22
Hricik, D.E.; Levine, B.S.; Adrogue, H.J.; Weinberg, M.S.; Goldstein, R. 1996: Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction. Enalapril/Diltiazem ER in Hypertensive Renal Disease Group Journal of Human Hypertension 10(11): 769-774
Tepliakov, A.T.; Vecherskiĭ, I.Iu.; Mamchur, S.E.; Dzhavadova, G.K.; Nemik, B.M. 2002: Postoperative spasm of mammary-coronary grafts and possibilities of its correction by dihydropyridine calcium antagonists nifedipine and amlodipine Kardiologiia 42(10): 9-14
Teo, K.K.; Burton, J.R.; Buller, C.; Plante, S.; Yokoyama, S.; Montague, T.J. 1997: Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators Canadian Journal of Cardiology 13(6): 591-599
Wilson, S.A.; Sanford, A. 2006: Amlodipine/atorvastatin (Caduet) for preventing heart disease American Family Physician 73(6): 1067-1068
Del Vecchio, L.; Pozzi, M.; Salvetti, A.; Maschio, G.; Fusaroli, M.; Rovati, C.; Antonucci, F.; Cascone, C.; Scanferla, F.; Panichi, V.; Sturani, A.; Locatelli, F. 2004: Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril Journal of Nephrology 17(2): 261-269
Opie, L.H. 1991: Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine Postgraduate Medical Journal 67 Suppl. 5: S2-S8
1991: Amlodipine in cardiovascular disease: the need for 24-hour protection and control. Proceedings of a meeting, Hong Kong, February 17, 1990 Postgraduate Medical Journal 67 Suppl. 5: S1-62
Yamagishi, I.; Abe, T.; Kuribayashi, R.; Sekine, S.; Seki, K.; Shibata, T. 1996: Coronary artery bypass grafting in a patient with severe coronary disease due to Kawasaki disease: a case report Kyobu Geka. Japanese Journal of Thoracic Surgery 49(2): 151-154
Carstens, V.; Haum, A.; Grond, M.; Behrenbeck, D.W. 1986: Incidence of coronary artery disease and necessity for coronary angiography in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 83-85
Opherk, D.; Mäurer, W.; Mehmel, H.C.; Müller, J.H.; Zebe, H.; Kübler, W. 1976: Coronary circulation and myocardial O2 consumption in patients with coronary heart disease under isometric load and in maximal coronary dilatation Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1188-1190
Imai, S.; Matsubara, T.; Hori, T.; Nakagawa, I.; Ozaki, K.; Hatada, K.; Mezaki, T.; Nasuno, A.; Kubota, K.; Tanaka, T.; Aizawa, Y. 2001: Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries Journal of Cardiology 37(6): 293-299
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590